Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Co-stimulatory domains for use in genetically-modified cells

Co-stimulatory domains for use in genetically-modified cells

US Patent 10800833 · Granted Oct 13, 2020

Estimated economic value: $4,266,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Genetically-modified T cells comprising a modified intron in the T cell receptor2025
Rationally-designed single-chain meganucleases with non-palindromic recognition 2025
Methods for producing a complex transgenic trait locus2025
Polynucleotides encoding engineered meganucleases having specificity for recogni2024
Polynucleotides encoding engineered meganucleases having specificity for recogni2024
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)2023
Polynucleotides encoding engineered meganucleases having specificity for recogni2023
Engineered meganucleases specific for recognition sequences in the PCSK9 gene2023
Methods for producing a complex transgenic trait locus2022
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)2022
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)2022
Co-stimulatory domains for use in genetically-modified cells2022